
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
PHARMASEAL has announced that a U.S. health outcomes and technology company has selected Engility Clinical Trial Management system (CTMS) for the management and oversight of its clinical trial programs. Engility CTMS is a modern cloud-based enterprise trial management system used by medical device, biopharmaceutical, and CRO’s to aim to improve how they manage and control clinical trials.
For more information, click






